What emerging viral pathogens should clinicians be aware of?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emerging Viral Pathogens Requiring Clinical Awareness

Clinicians should maintain heightened vigilance for chikungunya virus, which has demonstrated epidemic spread from East Africa through South and Southeast Asia with documented transmission in Europe, alongside dengue virus as the most common arboviral infections in returning travelers. 1

Priority Arboviruses with Expanding Geographic Range

Chikungunya Virus

  • Epidemic expansion: Originated in Mauritius and spread to large areas of South and Southeast Asia, with transmission documented in Italy in 2007 1
  • Increasing incidence: Being reported with growing frequency in travelers returning to Europe 1
  • Transmission: Day-biting Aedes mosquitoes, particularly Aedes aegypti 1
  • Incubation: 2-3 days (range: 1-12 days) 1
  • Clinical presentation: Polyarthralgia or arthritis as distinguishing feature 1

Dengue Virus

  • Global burden: 50-100 million cases annually across >100 countries 1
  • Geographic distribution: Throughout tropics, particularly Asia and South America 1
  • Clinical significance: Most common arbovirus in returning travelers, especially from Asia 1
  • Spectrum of illness: Ranges from mild febrile illness to dengue hemorrhagic fever (DHF) or dengue shock syndrome, though severe forms are rare in travelers 1
  • Incubation: 4-8 days (range: 3-14 days) 1

Pandemic Influenza Threats

Avian Influenza A/H5N1

  • Ongoing outbreak: Massive and unprecedented outbreak in poultry across East and Southeast Asia since late 2003, still continuing 1
  • Human cases: Small number but high mortality rate 1
  • Epidemiological changes: Recent reports from northern Vietnam suggest the virus may be adapting to humans 1
  • Pandemic potential: While emergence of human-to-human transmission is neither inevitable nor imminent, international concern remains elevated regarding A/H5N1 evolving into the next pandemic strain 1

Additional Emerging Viral Pathogens

Vertical Transmission Concerns

  • Ebola virus: Emerging pathogen with potential for mother-to-fetus transmission 2
  • Zika virus: Demonstrated transplacental spread causing congenital malformations 2
  • West Nile virus and Rift Valley fever virus: Emerging arboviruses with vertical transmission potential 2

Respiratory Coronaviruses

  • SARS-CoV and MERS-CoV: Established as emerging respiratory pathogens requiring institutional preparedness 3, 4
  • SARS-CoV-2: While rarely showing transplacental spread, the COVID-19 pandemic highlighted the importance of surveillance for rapidly evolving transmission patterns 2

Regional Arboviral Threats

Tick-Borne Encephalitis

  • Geographic restriction: Central and Eastern Europe 1
  • Clinical presentation: Encephalitis as primary manifestation 1

Other Arboviruses

  • Japanese encephalitis, Ross River, Barmah Forest, Sindbis viruses: Over 500 arboviruses exist, though most cause self-limiting illness 1
  • Clinical presentations: Four main patterns - systemic febrile illness, hemorrhagic fever, encephalitis, or polyarthralgia/arthritis 1

Critical Clinical Pitfalls

Common mistake: Assuming all arboviral infections are self-limiting. Murine typhus and scrub spotted fever can be fatal with mortality rates up to 32% and 4%, respectively 1

Travel history is essential: Geographic distribution varies significantly - dengue predominates in Asia and South America, while chikungunya has specific epidemic zones 1

Coinfections matter: Mixed viral infections occur in up to 40% of viral respiratory tract infections requiring hospitalization, potentially affecting outcomes and length of stay 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A Review of Emerging Viral Pathogens and Current Concerns for Vertical Transmission of Infection.

Medical science monitor : international medical journal of experimental and clinical research, 2024

Research

Preface - Emerging Viruses: From Early Detection to Intervention.

Advances in experimental medicine and biology, 2017

Related Questions

In a 46-year-old woman with chronic neck and back pain who now has a six-week history of bilateral hand numbness and full range of motion, what are the appropriate next diagnostic tests?
What is the likely cause of a 48-year-old woman's severe right lower abdominal pain radiating to the back that begins 30–60 minutes after she drinks her morning coffee?
What is the next best step in evaluating a healthy 13-year-old with absent puberty, bone age of 11.5 years, and height 157 cm?
What preventive evaluations, screenings, and immunizations are recommended for a healthy 40-year-old during a routine periodic visit?
What is the most likely diagnosis for a patient presenting with multiple painful, swollen nodules on the abdomen?
What is the appropriate workup and management for a patient presenting with scattered non‑blanching petechiae on the abdomen, arms, and legs?
What is the recommended maintenance (suppressive) therapy for HSV infection?
What is the recommended management for a 36-year-old female with a one-week history of sore throat, ear fluid (eustachian tube dysfunction), and sinus pressure?
What is the recommended management of a peritonsillar abscess?
What is the appropriate intravenous ceftriaxone dose for a 25‑kg pediatric patient?
In an 81-year-old woman with multiple prior strokes, coronary artery bypass graft, repaired abdominal aortic aneurysm, chronic kidney disease (eGFR ~49 mL/min/1.73 m²), intolerance to ezetimibe and statins, and elevated LDL‑C and non‑HDL‑C, which medication is indicated to lower cholesterol?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.